Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vishal Thapar

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cancer Discovery|August 8, 2014
Development of siRNA payloads to target KRAS-mutant cancerTina L Yuan, Christof Fellmann, Chih-Shia Lee, et al.
Cancer Discovery|April 22, 2016
BRD4 Connects Enhancer Remodeling to Senescence Immune SurveillanceNilgun Tasdemir, Ana Banito, Jae-Seok Roe, et al.
Nature Methods|February 21, 2006
Minimotif Miner: a tool for investigating protein functionSudha Balla, Vishal Thapar, Snigdha Verma, et al.
Biomaterials|April 16, 2016
A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinomaLaura Indolfi, Matteo Ligorio, David T Ting, et al.
Nature Biotechnology|March 7, 2017
Prediction of potent shRNAs with a sequential classification algorithmRaphael Pelossof, Lauren Fairchild, Chun-Hao Huang, et al.
Nature Communications|January 14, 2018
Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesiclesEduardo Reátegui, Kristan E van der Vos, Charles P Lai, et al.
Nature Communications|November 25, 2017
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cellsKeith H K Wong, Shannon N Tessier, David T Miyamoto, et al.
Cancer Cell|December 3, 2014
EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcomaNicolò Riggi, Birgit Knoechel, Shawn M Gillespie, et al.
The Journal of Clinical Investigation|June 16, 2022
Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotypeRebecca L Porter, Siyu Sun, Micayla N Flores, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2019
Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinomaRebecca L Porter, Neelima K C Magnus, Vishal Thapar, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cancer Discovery|August 8, 2014
Development of siRNA payloads to target KRAS-mutant cancerTina L Yuan, Christof Fellmann, Chih-Shia Lee, et al.
Cancer Discovery|April 22, 2016
BRD4 Connects Enhancer Remodeling to Senescence Immune SurveillanceNilgun Tasdemir, Ana Banito, Jae-Seok Roe, et al.
Nature Methods|February 21, 2006
Minimotif Miner: a tool for investigating protein functionSudha Balla, Vishal Thapar, Snigdha Verma, et al.
Biomaterials|April 16, 2016
A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinomaLaura Indolfi, Matteo Ligorio, David T Ting, et al.
Nature Biotechnology|March 7, 2017
Prediction of potent shRNAs with a sequential classification algorithmRaphael Pelossof, Lauren Fairchild, Chun-Hao Huang, et al.
Nature Communications|January 14, 2018
Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesiclesEduardo Reátegui, Kristan E van der Vos, Charles P Lai, et al.
Nature Communications|November 25, 2017
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cellsKeith H K Wong, Shannon N Tessier, David T Miyamoto, et al.
Cancer Cell|December 3, 2014
EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcomaNicolò Riggi, Birgit Knoechel, Shawn M Gillespie, et al.
The Journal of Clinical Investigation|June 16, 2022
Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotypeRebecca L Porter, Siyu Sun, Micayla N Flores, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2019
Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinomaRebecca L Porter, Neelima K C Magnus, Vishal Thapar, et al.
Pageof 3